Summary:
- Galera Therapeutics, a clinical-stage biopharmaceutical company, has completed the acquisition of Nova Biologics, a company focused on developing novel therapeutic approaches for cancer.
- The acquisition will allow Galera to expand its pipeline and leverage Nova's expertise in developing targeted therapies for cancer treatment.
- This strategic move aligns with Galera's mission to advance innovative cancer treatments and improve patient outcomes.